Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for type 2 diabetes treatment and weight management. This synthetic peptide demonstrates superior efficacy in glucose control compared to selective GLP-1 receptor agonists.
The compound features a modified lysine side chain with PEGylation, enhancing its water solubility and biological activity. Clinical trials have demonstrated significant weight loss results, with the 15mg dosage showing average reductions of approximately 20.9% body weight after 72 weeks of treatment.
As a research chemical, Tirzepatide 15mg offers scientists a valuable tool for studying metabolic disorders. The peptide's unique dual agonist mechanism provides insights into both GIP and GLP-1 receptor pathways, making it particularly interesting for diabetes and obesity research applications.
Our pharmaceutical grade Tirzepatide 15mg is produced under strict quality controls, ensuring high purity and consistency for research purposes. The compound is supplied as a white lyophilized powder with documented analytical reports.
Important Note: This product is intended for research use only by qualified professionals. Not for human consumption or diagnostic use.
